Literature DB >> 8088094

Clinical exercise testing in interstitial lung disease.

D D Marciniuk1, C G Gallagher.   

Abstract

Clinical exercise testing has become an essential tool used in the early diagnosis, in the monitoring of treatment effectiveness, and in the assessment of impairment owing to ILD. Despite the assorted causes, the responses to exercise demonstrated by these diseases are generally similar. Although much has been learned about how these diverse diseases functionally impair the exercise capacity of the patient, further study is required if we are to understand fully the various physiologic abnormalities manifested by patients with ILD during exercise.

Entities:  

Mesh:

Year:  1994        PMID: 8088094

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  6 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Does nebulized fentanyl relieve dyspnea during exercise in healthy man?

Authors:  Houssam G Kotrach; Jean Bourbeau; Dennis Jensen
Journal:  J Appl Physiol (1985)       Date:  2015-03-12

3.  Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive.

Authors:  Cassandra T Mendonca; Michele R Schaeffer; Patrick Riley; Dennis Jensen
Journal:  J Appl Physiol (1985)       Date:  2013-12-19

4.  Effect of cardiac resynchronization therapy on pulmonary function in patients with heart failure.

Authors:  Ivan Cundrle; Bruce D Johnson; Virend K Somers; Christopher G Scott; Robert F Rea; Lyle J Olson
Journal:  Am J Cardiol       Date:  2013-06-05       Impact factor: 2.778

5.  Assessment of Measurement Reliability for the IPN Test in Cardiac Patients.

Authors:  Łukasz Oleksy; Agnieszka Skiba; Iwona Sulowska; Marcin Trębowicz; Bartosz Rukasz; Artur Stolarczyk; Joanna Zyznawska; Anna Mika
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

6.  Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis.

Authors:  A J Lopes; S L S Menezes; C M Dias; J F Oliveira; M R M Mainenti; F S Guimarães
Journal:  Braz J Med Biol Res       Date:  2012-02-16       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.